Labshake search
Citations for R&D Systems :
501 - 550 of 975 citations for 10 Methylundecanoic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Synthetic Biology 2020Quote: ... 10 ng/mL transforming growth factor beta 3 (TGF-β3, R&D Systems) and 100nM dexamethasone12,27 to make implantable cartilage constructs11 ...
-
bioRxiv - Immunology 2019Quote: ... cells were cultured with or without TGFβ (10 ng/ml; R&D Systems), rapamycin (20 nM ...
-
bioRxiv - Pathology 2020Quote: ... or 10 ng/mL TNF-α (Cat#210-TA-020, R&D Systems) for 24 hours ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/mL basic fibroblast growth factor (bFGF; R&D Systems, Minneapolis, MN), 10 ng/mL epidermal growth factor (EGF ...
-
bioRxiv - Cell Biology 2020Quote: ... and 10 ng/ml IL-1β (R&D Systems Inc., Minneapolis, Minnesota, USA) (treatment) ...
-
bioRxiv - Biochemistry 2022Quote: ... supplemented in 10% fetal bovine serum (FBS, R&D Systems, Inc., Minneapolis, MN) and 1% penicillin-streptomycin (P/S ...
-
bioRxiv - Microbiology 2022Quote: ... supplemented with 10% fetal bovine serum (FBS) (S10350; R&D systems, Minneapolis, MN) and 1% penicillin-streptomycin solution (15140-122 ...
-
bioRxiv - Genomics 2022Quote: ... and murine IL-6 10 ng/mL (R&D Systems #406-ML-025), in a 37°C and 5% CO2 atmospheric environment.
-
bioRxiv - Genomics 2022Quote: ... and supplemented with 10% (v/v) standard FBS (VWR or R&D Systems), 100 units/mL penicillin ...
-
bioRxiv - Neuroscience 2022Quote: ... 10 ng/ml platelet-derived growth factor-AA (PDGF-AA, R&D systems) and insulin-like growth factor-1 (IGF-1 ...
-
bioRxiv - Immunology 2022Quote: ... IL-10 and IL-22 (DuoSet ELISA R&D Systems, Minneapolis, MN, USA) IFN-γ (Invitrogen ...
-
bioRxiv - Molecular Biology 2023Quote: ... Recombinant human (rh) TGF-β (10 ng/mL, R&D Systems, 7754-BH) was applied to NHLF cell line only to induce LOX expression ...
-
bioRxiv - Cell Biology 2023Quote: ... cells were treated with 10 ng/mL TNFα (R&D Systems: #410-MT) for up to 10 h followed by the isolation of RNA and protein for qPCR and immunoblot ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 10 ng/ml Nrg1 (HRG-beta-1 EGF domain) (R&D Systems) on poly-L-lysine (50 μg/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... and mouse IgG1-PE conjugate (10 uL for LGR5; R&D Systems #IC002P). It is worth noting that only the LRIG1 was incubated with a secondary antibody conjugated to allophycocyanin (APC ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/mL of IL-4 (R&D systems, 402-ML-020)) ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/mL of IL-2 (R&D systems, 404-ML-010)) ...
-
Lysyl oxidase regulates epithelial differentiation and barrier integrity in eosinophilic esophagitisbioRxiv - Cell Biology 2023Quote: ... 10 ng/ml recombinant BMP2 protein (R&D Systems, Inc., Minneapolis, MN, USA), or vehicle (phosphate-buffered saline for IL-13 and hydrochloride for BMP2 ...
-
bioRxiv - Immunology 2023Quote: ... Cells were then stimulated with recombinant TGFβ2 (10 ng/mL, R&D Systems), recombinant CXCL4 (5 µg/mL ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 10% fetal bovine serum (FBS, R&D Systems, Minneapolis, MN, USA) and 1% penicillin-streptomycin solution (ThermoFischer Scientific ...
-
bioRxiv - Bioengineering 2023Quote: ... The medium was supplemented with 10% fetal bovine serum (FBS, R&D Systems), 1% Penicillin/Streptomycin (Corning ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 10 ng/ml EGF (23626, R&D Systems, Minneapolis, MN, USA), 1 μg/ml hydrocortisone (0219456901 ...
-
bioRxiv - Bioengineering 2023Quote: ... 1x Penn/Strep and 10 ng ml-1 activin (R&D Systems, 338AC010CF). On Day 7 media was changed to Advanced RPMI 1640 Medium ...
-
bioRxiv - Bioengineering 2024Quote: ... and 10 ng/ml fibroblast growth factor-2 (R&D Systems, Minneapolis, MN). For pellet cultures ...
-
bioRxiv - Cell Biology 2023Quote: ... 10 ng/mL basic FGF (R&D Systems #233-FB/CF, Minneapolis, MN), 1% P/S ...
-
bioRxiv - Neuroscience 2020Quote: ... and human recombinant FGF2 (10 ng/ml, R&D Systems, Minneapolis, Minnesota; 233-FB). After two to three weeks ...
-
bioRxiv - Neuroscience 2020Quote: ... From day 10 the medium was supplemented with 3nM recombinant SHH (R&D Systems), 50ng/μl acidic fibroblast growth factor (αFGF ...
-
bioRxiv - Neuroscience 2020Quote: ... and mouse anti-smooth muscle actin (SMA, 10 μg/ml, MAB1420, R&D Systems). Cells were then immunostained with isotype-specific secondary antibodies (Alexa Fluor 568 or 488 ...
-
bioRxiv - Cell Biology 2021Quote: ... 0.1% 2-Mercaptoethanol and 10 ng/mL basic FGF (R&D Systems, 233-FB). For MyoD+F/R/C condition ...
-
bioRxiv - Microbiology 2021Quote: ... Transient transfection of poly(I:C) (Cat# 4287/10; R&D Systems, Minneapolis, MN, USA) was performed with Lipofectamine 2000 (Thermo Fisher Scientific ...
-
bioRxiv - Pathology 2021Quote: ... 1% antibiotics and 10 ng/ml basic fibroblast growth factor (bFGF) (R&D Systems). Human MPCs were trypsinized and incubated 30 min with biotinylated anti-human PDGFRα (R&D system ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with RGDS peptide (10 μg/mL, R&D systems, MN, USA) (20 ...
-
bioRxiv - Systems Biology 2020Quote: ... or mouse anti-TNFα Receptors 1 and 2 (10 µg/mL, R&D Systems) (see Figure 1-Figure Supplement 4B ...
-
bioRxiv - Biophysics 2022Quote: ... 0.4 mM proline and 10 ng/ml TGF-β3 (R&D Systems, Minneapolis, MN). Differentiation was carried out for 3 weeks ...
-
bioRxiv - Immunology 2020Quote: ... TNF-α (all eBioscience) and IL-10 and CXCL1 (R&D systems, Minneapolis, USA) according to the manufacturer’s instructions.
-
bioRxiv - Developmental Biology 2021Quote: ... 10 ng/mL bone morphometric protein-4 (BMP4, R&D Systems, cat#314-BP), 3 µM CHIR99021 (STEMCELL Technologies ...
-
bioRxiv - Microbiology 2022Quote: ... supplemented with 10% fetal bovine serum (FBS; R&D systems, Flower Branch, GA, USA), 1% antibiotic-antimycotic solutions (Gibco ...
-
bioRxiv - Immunology 2020Quote: ... and CXCL10/IP-10 using commercially available ELISA kits (R&D Systems, Minnesota, USA). In select experiments ...
-
bioRxiv - Cancer Biology 2019Quote: ... 10 ng/ml rhIL-12 and 100 ng/ml rhIL-18 (R&D Systems). Where indicated ...
-
bioRxiv - Molecular Biology 2019Quote: ... contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat. # B-20), protease inhibitor cocktail ...
-
bioRxiv - Molecular Biology 2019Quote: ... contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat. # B-20), protease inhibitor cocktail ...
-
bioRxiv - Cancer Biology 2020Quote: ... cells were either treated with 10 ng/ml IL4 (R&D Systems, Abingdon, UK) or left untreated and incubated for 24 hours at 37°C/5%CO2 ...
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Bioengineering 2019Quote: ... groove multiwell array were coated with human fibronectin (10 μg/ml, R&D Systems) for 1 hour ...
-
bioRxiv - Cell Biology 2019Quote: ... 100µl of 10 µg/ml fibronectin or E-Cadherin (R&D System, 8875-EC) was applied to a 2X2 cm NoA 74 membrane on a polymer bottom dish (ibidi ...
-
bioRxiv - Cell Biology 2020Quote: ... and were treated with 10 ng/mL TGF-β1 (R&D systems, 240-B) or IMRC conditioned medium where specified ...
-
bioRxiv - Biochemistry 2021Quote: ... Treatments with human recombinant 10 ng/ml TGF-β1 (R&D Systems, Minneapolis, MN) were performed after serum-free starvation for 12 hours (h).
-
bioRxiv - Physiology 2020Quote: ... and IL-10 concentrations were measured using ELISA kits (TNF-α: R&D Systems, Minneapolis ...
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Bioengineering 2020Quote: ... cells were incubated with medium containing factors Wnt-C59 (5148/10, R&D systems) and BMP4 (SRP3016 ...